A breakthrough in the understanding of the atopic march was the discovery of the filaggrin loss-of-function mutations that provided genetic evidence linking skin barrier deficiency to eczema and subsequent asthma development8, 9. The gene discussed is FLG; the disease is Eczematoid dermatitis.